KCAT	Oryctolagus cuniculus	0.0283	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*
KCAT	Homo sapiens	1.6	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*
KCAT	Homo sapiens	2	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Bos taurus	4.7	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Bos taurus	7	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 5.5, 30&Acirc;&deg;C
KCAT	Canis lupus familiaris	12.4	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KCAT	Homo sapiens	14.4	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Bos taurus	15.1	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KCAT	Homo sapiens	20.3	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KCAT	Mus musculus	20.3	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KCAT	Homo sapiens	21	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*
KCAT	Saimiri boliviensis	33.1	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KCAT	Bos taurus	40.5	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Oryctolagus cuniculus	0.000000548	Collagen	*alpha-chain
KCAT	Oryctolagus cuniculus	0.02	benzoyl-Phe-Val-Arg-7-amido-4-methylcoumarin	*
KCAT	Bos taurus	13	benzoyl-Phe-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Homo sapiens	2.9	benzyloxycarbonyl-Phe-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Homo sapiens	0.45	(7-[[(2S)-2-(4-[(1S)-1,2-dimethyl-1-[(phenylcarbonyl)amino]propyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KCAT	Homo sapiens	1.1	benzyloxycarbonyl-Leu-Leu-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Rattus norvegicus	30	butyloxycarbonyl-Val-Leu-Lys-7-amido-4-methylcoumarin	*
KCAT	Rattus norvegicus	65	butyloxycarbonyl-Val-Leu-Lys-7-amido-4-methylcoumarin	*
KCAT	Bos taurus	6.1	tert-butyloxycarbonyl-Phe-Leu-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Bos taurus	8.6	tert-butyloxycarbonyl-Phe-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Homo sapiens	0.46	(4-methyl-7-[[(2S)-2-(4-[(1S)-1-(4-methylcyclohexyl)-1-[(thiophen-3-ylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-2-oxo-2H-chromen-3-yl)acetic acid	*
KCAT	Homo sapiens	0.77	(7-[[(2S)-2-(4-[(1S)-1,2-dimethyl-1-[(thiophen-3-ylcarbonyl)amino]propyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KCAT	Homo sapiens	0.2	(7-[[(2S)-2-(4-[(1S)-1-cyclohexyl-1-[(phenylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KCAT	Homo sapiens	0.22	(7-[[(2S)-2-(4-[(1S)-1-cyclohexyl-1-[(thiophen-3-ylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KCAT	Homo sapiens	44	GRWHKLSVRWE	*in 0.1 M citrate buffer, pH 5.5 containing 4 mM dithiothreitol, at 37&Acirc;&deg;C
KCAT	Homo sapiens	11	GRWHKFSVRWE	*in 0.1 M citrate buffer, pH 5.5 containing 4 mM dithiothreitol, at 37&Acirc;&deg;C
KCAT	Homo sapiens	3	GRWHKISVRWE	*in 0.1 M citrate buffer, pH 5.5 containing 4 mM dithiothreitol, at 37&Acirc;&deg;C
KCAT	Homo sapiens	5.666	(7-methoxycoumarin-4-yl)-acetyl-GRWPPMGLPWEK(2,4-dinitrophenyl)-D-Arg-NH2	*
KCAT	Homo sapiens	2.5	o-aminobenzoic acid-Leu-Glu-Gln-(N-[2,4-dinitrophenyl]ethylenediamine)	*
KCAT	Homo sapiens	3.3	butyloxycarbonyl-Phe-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KCAT	Homo sapiens	-999	more	*
KCAT	Mus musculus	-999	more	*
KCAT	Rattus norvegicus	-999	more	*
KCAT	Oryctolagus cuniculus	0.000000000583	gelatin	*alpha-chain
KCAT	Oryctolagus cuniculus	0.000000011	azocasein	*in presence of urea
KM	Bos taurus	0.0147	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Homo sapiens	0.0182	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*
KM	Rattus norvegicus	0.019	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 7.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0208	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Bos taurus	0.042	benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin	*pH 5.5, 30&Acirc;&deg;C
KM	Bos taurus	0.006	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KM	Mus musculus	0.011	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KM	Canis lupus familiaris	0.013	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KM	Homo sapiens	0.014	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KM	Homo sapiens	0.0158	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*
KM	Bos taurus	0.0175	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Homo sapiens	0.0177	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Homo sapiens	0.0184	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*at pH 6.5 and 37&Acirc;&deg;C
KM	Saimiri boliviensis	0.024	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 5.0, room temperature
KM	Rattus norvegicus	0.288	benzyloxycarbonyl-Val-Val-Arg-7-amido-4-methylcoumarin	*pH 7.5, 37&Acirc;&deg;C
KM	Bos taurus	0.0081	benzoyl-Phe-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Homo sapiens	0.0121	benzyloxycarbonyl-Phe-Val-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Homo sapiens	0.0125	benzyloxycarbonyl-Phe-Val-Arg-7-amido-4-methylcoumarin	*in 50 mM sodium phosphate buffer, pH 6.5, containing 2.5 mM EDTA and 0.1% PEG-6000
KM	Homo sapiens	0.41	(7-[[(2S)-2-(4-[(1S)-1,2-dimethyl-1-[(phenylcarbonyl)amino]propyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KM	Homo sapiens	0.0034	benzyloxycarbonyl-Leu-Leu-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Bos taurus	0.0073	tert-butyloxycarbonyl-Phe-Leu-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Bos taurus	0.0375	tert-butyloxycarbonyl-Phe-Phe-Arg-7-amido-4-methylcoumarin	*pH 6.5, 25&Acirc;&deg;C
KM	Homo sapiens	0.017	(4-methyl-7-[[(2S)-2-(4-[(1S)-1-(4-methylcyclohexyl)-1-[(thiophen-3-ylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-2-oxo-2H-chromen-3-yl)acetic acid	*
KM	Homo sapiens	0.3	(7-[[(2S)-2-(4-[(1S)-1,2-dimethyl-1-[(thiophen-3-ylcarbonyl)amino]propyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KM	Homo sapiens	0.057	(7-[[(2S)-2-(4-[(1S)-1-cyclohexyl-1-[(phenylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KM	Homo sapiens	0.13	(7-[[(2S)-2-(4-[(1S)-1-cyclohexyl-1-[(thiophen-3-ylcarbonyl)amino]ethyl]-1H-1,2,3-triazol-1-yl)hexanoyl]amino]-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid	*
KM	Homo sapiens	0.09	GRWHKLSVRWE	*in 0.1 M citrate buffer, pH 5.5 containing 4 mM dithiothreitol, at 37&Acirc;&deg;C
KM	Homo sapiens	0.17	GRWHKFSVRWE	*in 0.1 M citrate buffer, pH 5.5 containing 4 mM dithiothreitol, at 37&Acirc;&deg;C
KM	Homo sapiens	0.04	GRWHKISVRWE	*in 0.1 M citrate buffer, pH 5.5 containing 4 mM dithiothreitol, at 37&Acirc;&deg;C
KM	Homo sapiens	0.00556	(7-methoxycoumarin-4-yl)-acetyl-GRWPPMGLPWEK(2,4-dinitrophenyl)-D-Arg-NH2	*
KM	Homo sapiens	0.0015	o-aminobenzoic acid-Leu-Glu-Gln-(N-[2,4-dinitrophenyl]ethylenediamine)	*
KM	Homo sapiens	0.00142	GRWHFVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00194	GRWHKVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00276	GRWHVVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00514	GRWHGVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00188	GRWHDVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0016	GRWH-norleucine-VGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00324	GRWHPVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00048	GRWHIVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0021	GRWHTFGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00782	GRWHTKGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0093	GRWHTTGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01286	GRWHTGGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01237	GRWHTDGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00418	GRWHT-norleucine-GLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00591	GRWHTPGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00395	GRWHTIGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00779	GRWHTMGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00258	GRWHTVFLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.02747	GRWHTVKLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0249	GRWHTVQLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00506	GRWHTVTLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0028	GRWHTVDLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01047	GRWHTV-norleucine-LRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01998	GRWHTVPLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00512	GRWHTVILRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0048	GRWHTVGFRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00525	GRWHTVGKRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00237	GRWHTVGVRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00171	GRWHTVG-citrulline-RWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00073	GRWHTVG-norleucine-RWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00244	GRWHTVGRRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00198	GRWHTVGIRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00237	GRWHTVGLRWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00527	GRWHTVGLFWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00105	GRWHTVGLKWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00312	GRWHTVGLHWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00259	GRWHTVGLQWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00314	GRWHTVGLDWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.00131	GRWHTVGLPWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0015	GRWHTVGLIWE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0082	GRWHTVGLRFE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.03787	GRWHTVGLRKE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01493	GRWHTVGLRHE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01648	GRWHTVGLRGE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01668	GRWHTVGLRDE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.01154	GRWHTVGLRRE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0082	GRWHTVGLRIE-Lys(2,4-dinitrophenyl)-D-Arg-NH2	*0.02 mM substrate, 1.3 nM CatS, 50 mM sodium acetate, 4 mM dithiothreitol, pH 5.5, 37&Acirc;&deg;C
MW	Homo sapiens	16000	*	*His-tagged recombinant propeptide, SDS-PAGE
MW	Bos taurus	20000	*	*gel filtration
MW	Bos taurus	23682	*	*x * 23682, calculation from nucleotide sequence
MW	Bos taurus	23700	*	*x * 23700, calculation from nucleotide sequence
MW	Bos taurus	24000	*	*x * 24000, SDS-PAGE
MW	Homo sapiens	24000	*	*x * 24000, SDS-PAGE
MW	Homo sapiens	24000	*	*x * 24000, SDS-PAGE
MW	Homo sapiens	24000	*	*x * 24000, SDS-PAGE
MW	Bos taurus	24000	*	*1 * 24000
MW	Homo sapiens	24000	*	*activated CatS is a single chain polypeptide
MW	Mus musculus	24000	*	*x * 24000, 2-D gel electrophoresis
MW	Homo sapiens	24560	*	*calculated from amino acid sequence
MW	Homo sapiens	25000	*	*SDS-PAGE
MW	Homo sapiens	25000	*	*Western blot
MW	Canis lupus familiaris	26000	*	*x * 26000, SDS-PAGE
MW	Saimiri boliviensis	26000	*	*x * 26000, SDS-PAGE
MW	Oryctolagus cuniculus	30000	*	*gel filtration
MW	Oryctolagus cuniculus	30500	*	*gel filtration
MW	Homo sapiens	36000	*	*inactive precursor
MW	Ictalurus punctatus	36700	*	*calculated from 329-amino acid sequence, the complete CTSS cDNA comprises 1530 nucleotides including a 96-nucleotide 5'-untranslated region, a 990-nucleotide open reading frame and a 444-nucleotide 3'-untranslated region
MW	Rattus norvegicus	37000	*	*proform of CATS, confirmed by Western blot analysis
SA	Homo sapiens	-999	*	*Cat S activity quantification in serum of healthy persons and atherosclerosis and/or diabetes patients, non-atheroma, and atheroma patients with myocardial infarction, overview
SA	Homo sapiens	-999	*	*
SA	Mus musculus	-999	*	*
SA	Mus musculus	-999	*	*leucocyte CatS deficiency leads to a markedly altered plaque morphology and composition, which can in part be attributed to fewer elastic lamina ruptures and a higher resistance of macrophages to apoptosis and necrosis
SA	Rattus norvegicus	-999	*	*expression and activity of CATS is upregulated in the spinal cord during the development and progression of neuropathic pain in the CNS of the rat 5th lumbar spinal nerve transection model after the lesion, the strongest increase in protein content is found in the thoracic segment (63.6%)
SA	Mus musculus	-999	*	*CATS protein expression increases in the cerebral cortex, the cerebellum and the hippocampus, the proform is the predominant enzymatic form in all analyzed age groups; CATS transcript and protein are strongly increased between 3 and 5 months of age in the central nervous system of SOD1-G93A transgenic mice with amyotrophic lateral sclerosis; in a transgenic mouse model of amyotrophic lateral sclerosis expressing mutant superoxide dismutase 1, CATS transcript and protein levels are significantly upregulated in spinal cord and lower brain regions displaying neuronal degeneration; the number of CATS immunopositive cells with glial morphology clearlyincreases in 4-week- and 26-30-month old mice
SA	Mus musculus	-999	*	*osteogenic activity decreases in apolipoprotein-/-/catS-/- mouse aortas with chronic renal disease
SA	Homo sapiens	-999	*	*an independent obese adult population, associations between 3 CTSS variants (rs10888390, rs10888394 and rs1136774) and plasma Apo-A1 levels in women are found; cathepsin S genotypes are associated with Apo-A1 and HDL-cholesterol in lean and obese French populations; CTSS circulating levels are increased in obese individuals and decreased following weight loss induced by gastric surgery; CTSS contributes independently to plasma Apo-A1 and HDL-Clevels in both healthy and obese populations, with the most prominent CTSS polymorphism (rs10888390) explaining 3.8% of the variance in plasma Apo-A1 phenotype levels in obese women; CTSS sequence variations are associated with two human metabolic risk factors for cardiovascular diseases, plasma Apo-A1 and HDL-C concentrations; CTSS sequence variations are associated with two human metabolic risk factors for cardiovascular diseases: plasma Apo-A1 and HDL-C concentrations; in a lean cohort, which corresponds to a general French population, significant associations between the rs11576175 variant and the plasma Apo-A1 and HDL-C in women and men are identified
SA	Ovis aries	-999	*	*cathepsin S, a cellular enzyme shows enhanced expression in pathogenic conditions
SA	Homo sapiens	-999	*	*dendritic and B-cells show significantly lower endosomal CatS activity compared with macrophages, the CatS activity in endosomal extracts from macrophages is 10times higher than in the corresponding extracts from B-cell line and even 30times higher than in endosomal fractions from dendritic cells, CatS activity differs not only between the different types of antigen presenting sells but also between endosomal and lysosomal compartments of one cell type; macrophage endosomal extracts even show a 600fold higher CatS activity compared with lysosomal extracts
SA	Ictalurus punctatus	-999	*	*up-regulation of cathepsin S transcript during the early stage of Edwardsiella ictaluri infection, leading to speculate that CTSS may play a role in infection
SA	Homo sapiens	-999	*	*the median tear CTSS activity in patients with Sj&ouml;gren's syndrome is 4.1fold higher than that in patients with other autoimmune diseases, 2.1fold higher than that in patients with nonspecific dry eye disease, and 41.1fold higher than that in healthy control subjects
SA	Bos taurus	0.582	*	*
SA	Homo sapiens	7200	*	*
